Leptin Canan Karatay

СПИСОК ЛИТЕРАТУРЫ

1. Автандилов, Г. Г. Медицинская морфометрия [Текст] : руководство / Г. Г. Автандилов. - Москва : Медицина, - с. : ил.

2. Аранесп (Aranesp) [Электронный ресурс] // РЛС : реестр лекарственных средств России : энцикл. лекарств и товаров аптечного ассортимента. - Москва, - Режим доступа: seafoodplus.info

3. Арустамова, А. А. Противоишемическое и эндотелиопротективное действие потенцированных антител к эндотелиальному фактору роста сосудов [Текст] : дис. канд. биол. наук : / А. А. Арустамова. - Белгород, - с. : ил., табл.

4. Влияние мексидола и сулодексида на уровень специфических маркеров развития эндотелиальной дисфункции у животных с экспериментальным сахарным диабетом [Текст] / И. Н. Тюренков, А. В. Воронков, А. А. Слиецанс [и др.] // Экспериментальная и клиническая фармакология. - - Т. 75, № 5. - С.

5. Глазные болезни [Текст] : учебник для студентов мед. вузов / Т. И. Ерошевский [и др.] ; под ред. А. П. Нестерова, В. М. Малова. - 4-е изд., перераб. и доп. - Москва : Лидер-М, - с. - (Учеб. лит. для студентов мед. вузов).

6. Диабетическая ретинопатия: механизмы развития [Текст] / Э. В. Мальцев, С. С. Родин, М. Р. Махмуд [и др.] // Офтальмологический журнал. - - № 2. -С.

7. Иванова, Н. В. Дисбаланс в системе гемостаза и эндотелиальная дисфункция у больных с диабетической ретинопатией [Текст] / Н. В. Иванова, Н. А. Ярошева // Офтальмологический журнал. - - № 3. - С.

8. Изучение влияния сулодексида на эндотелий-зависимую вазодилатацию мозговых сосудов у животных со стрептозотоцин-индуцированным сахарным диабетом [Текст] / И. Н. Тюренков, А. В. Воронков, А. А. Слиецанс [и др.] // Сахарный диабет. - - № 3. - С.

9. Изучение протективных свойств эритропоэтина и никорандила на модели

ишемии-реперфузии сетчатки [Текст] / А. С. Шабельникова, А. С. Кашуба, А. А. Пересыпкина [и др.] // Современные наукоемкие технологии. - - № - С.

Кацнельсон, Л. А. Сосудистые заболевания глаз [Текст] / Л. А. Кацнельсон, Т. И. Форофонова, А. Я. Бунин. - Москва : Медицина, - с.

Классификация форм гипертонической ретинопатии на основе оценки биоэлектрического потенциала сетчатки и контрастной чувствительности [Текст] / А. М. Шамшинова, М. А. Аракелян, С. Ю. Рогова [и др.] // Вестник офтальмологии. - - Т. , № 1. - С.

Константинова, Т. С. Протекторная и нейротоксическая роль оксида азота в моделях зрительных патологий [Текст] : автореф. дис. канд. биол. наук : / Т. С. Константинова. - Москва, - 26 с.

Коррекция гипертензивной нейроретинопатии производным диметиламиноэтанола в эксперименте [Текст] / А. А. Пересыпкина, М. В. Покровский, В. О. Губарева [и др.] // Кубанский научный медицинский вестник. - Т. 25, № 1. - С.

Нероев, В. В. Ишемия сетчатки и оксид азота [Текст] / В. В. Нероев, М. М. Архипова // Вестник Российской академии медицинских наук. - - № 5. - С.

Офтальмология [Текст] : нац. руководство / Общерос. обществ. орг. «Ассоциация врачей-офтальмологов» [и др.] ; под ред. С. Э. Аветисова, Е. А. Егорова, Л. К. Мошетовой [и др.]. - 2-е изд., перераб. и доп. - Москва : ГЭОТАР-Медиа, - с.

Пересыпкина, А. А. Пути фармакологической коррекции повреждений сетчатки в эксперименте [Текст] : дис. д-ра биол. наук : / А. А. Пересыпкина. - Белгород, - с. : ил.

Ранние проявления гипертонической ангиохориоретинопатии у подростков с эссенциальной артериальной гипертензией [Текст] / Ю. Н. Савина, С. И. Жукова, Т.Н. Юрьева [и др.] // Офтальмохирургия. - - № 3. - С.

Саркисов, К. Г. Лазерная допплеровская флоуметрия как метод оценки состояния кровотока в микрососудах [Текст] / К. Г. Саркисов, Г. В. Дужак // Методология флоуметрии : сб. ст. / Фирма «Трансоник». - Москва, - Вып. 3. - С.

Сравнительное исследование морфофункциональных нарушений при моделировании ADMA-подобной преэклампсии и гипоперфузии в плаценте [Электронный ресурс] / О. Е. Анциферова, Т. И. Локтева, А. А. Должиков [и др.] // Современные проблемы науки и образования : электрон. науч. журн. - - № 4. - Режим доступа: seafoodplus.info?id=

Телегина, Д. В. Молекулярные механизмы гибели клеток в сетчатке крыс при старении и развитии ретинопатии [Текст] : дис. канд. биол. наук : / Д. В. Телегина. - Новосибирск, - с.

Шабельникова, А. С. Коррекция ишемических повреждений сетчатки с использованием дистантного и фармакологического прекондиционирования рекомбинантным эритропоэтином [Текст] : дис. канд. биол. наук : / А. С. Шабельникова. - Белгород, - с.

Ярцева, Н. С. Избранные лекции по офтальмологии [Текст] : учеб. пособие для системы послевуз. проф. образования врачей : в 3 т. / Н. С. Ярцева, Л. А. Деев, Н. А. Гаврилова ; под ред. Х. П. Тахчиди. - Москва : ИЦ МНТК «Микрохирургия глаза», - Т. 3. - с.

A critical role of erythropoietin receptor in neurogenesis and post-stroke recovery [Text] / P. T. Tsai, J. J. Ohab, N. Kertesz [et al.] // J. Neurosci. - - Vol. 26, № 4. - P.

A review on the extraction of quantitative retinal microvascular image feature [Electronic resource] / K. Kipli, M. E. Hoque, L. T. Lim [et al.] // Comput. Math. Methods Med. - - Vol. - Art. - Mode of access: seafoodplus.info

Abnormalities of retinal microvascular structure and risk of mortality from ischemic heart disease and stroke [Text] / N. Witt, T. Y. Wong, A. D. Hughes [et al.] //

Hypertension. - - Vol. 47, № 5. - P.

Activation of the EPOR-ß common receptor complex by cibinetide ameliorates impaired wound healing in mice with genetic diabetes [Text] / A. Bitto, N. Irrera, G. Pizzino [et al.] // Biochim. Biophys. Acta Mol. Basis Dis. - - Vol. , № 2. -P.

Alrashdi, S. F. Intravitreal administration of endothelin type A receptor or endothelin type B receptor antagonists attenuates hypertensive and diabetic retinopathy in rats [Text] / S. F. Alrashdi, D. Deliyanti, J. L. Wilkinson-Berka // Exp. Eye Res. - Vol. - P.

ARA improves symptoms in patients with sarcoidosis-associated small nerve fiber loss and increases corneal nerve fiber density [Text] / A. Dahan, A. Dunne, M. Swartjes [et al.] // Mol. Med. - - Vol. - P.

ARA , a nonerythropoietic peptide engineered from erythropoietin, improves metabolic control and neuropathic symptoms in patients with type 2 diabetes [Text] / M. Brines, A.N. Dunne, M. van Velzen [et al.] // Mol. Med. - - Vol. - P.

Ardeljan, D. Aging is not a disease: distinguishing age-related macular degeneration from aging [Text] / D. Ardeljan, C. C. Chan // Prog. Retin. Eye Res. - Vol. - P.

Are retinal arteriolar or venular diameters associated with markers for cardiovascular disorders? The Rotterdam Study [Text] / M. K. Ikram, F. J. de Jong, J. R. Vingerling [et al.] // Invest. Ophthalmol. Vis. Sci. - - Vol. 45, № 7. - P.

Assessment of left atrium and diastolic dysfunction in patients with hypertensive retinopathy: A real-time three-dimensional echocardiography-based study [Text] / B. G. Kanar, H. S. Kanar, A. Karatay [et al.] // Clin. Exp. Hypertens. - -Vol. 39, № 8. - P.

Association of hypertensive retinopathy with angiographic severity of coronary artery disease determined by syntax score [Text] / S. A. Habib, M. S. Jibran, S. B. Khan [et al.] // J. Ayub Med. Coll. Abbottabad. - - Vol. 31, № 2. - P.

Biesenbach, G. High prevalence of hypertensive retinopathy and coronary heart disease in hypertensive patients with persistent microalbuminuria under short intensive antihypertensive therapy [Text] / G. Biesenbach, J. Zazgornik // Clin. Nephrol. - - Vol. 41, № 4. - P.

Both darbepoetin alfa and carbamylated erythropoietin prevent kidney graft dysfunction due to ischemia/reperfusion in rats [Text] / P. Cassis, N. Azzollini, S. Solini [et al.] // Transplantation. - - Vol. 92, № 3. - P.

Brines, M. Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response [Text] / M. Brines, A. Cerami // J. Intern. Med. - - Vol. , № 5. - P.

Brines, M. The therapeutic potential of erythropoiesis-stimulating agents for tissue protection: a tale of two receptors [Text] / M. Brines // Blood Purif. - -Vol. 29, № 2. - P.

Candesartan attenuates diabetic retinal vascular pathology by restoring glyoxalase-I function [Text] / A. G. Miller, G. Tan, K. J. Binger [et al.] // Diabetes. - Vol. 59, № - P.

Carbamylated darbepoetin derivative prevents endothelial progenitor cell damage with no effect on angiogenesis [Text] / R. Ramirez, J. Carracedo, S. Nogueras [et al.] // J. Mol. Cell. Cardiol. - - Vol. 47, № 6. - P.

Cardioprotection by a nonerythropoietic, tissue-protective peptide mimicking the 3D structure of erythropoietin [Text] / H. Ueba, M. Brines, M. Yamin [et al.] // Proc. Natl. Acad. Sci. USA. - - Vol. , № - P.

Cendrowski, J. Endocytic regulation of cytokine receptor signaling [Text] / J. Cendrowski, A. Maminska, M. Miaczynska // Cytokine Growth Factor Rev. - -Vol. - P.

Chaine, G. Hypertensive retinopathy [Text] / G. Chaine, E. M. Kohner // J. Fr.

Ophtalmol. - - Vol. 6, № - P.

Cicletanine and hypertensive retinopathy [Text] / M. M. Ruchoux, M. T. Droy-Lefaix, F. Bakri [et al.] // Ophthalmic Res. - - Vol. 22, № 5. - P.

Consideration of hypertensive retinopathy as an important end-organ damage in patients with hypertension [Text] / S. A. Kolman, A. M. van Sijl, F. A. van der Sluijs [et al.] // J. Hum. Hypertens. - - Vol. 31, № 2. - P.

Corneal nerve fiber size adds utility to the diagnosis and assessment of therapeutic response in patients with small fiber neuropathy [Electronic resource] / M. Brines, D. A. Culver, M. Ferdousi [et al.] // Sci. Rep. - - Vol. 8, № 1. - Art. - Mode of access: seafoodplus.info

Cyclic helix B peptide ameliorates acute myocardial infarction in mice by inhibiting apoptosis and inflammatory responses [Electronic resource]/ C. Yang, C. Zhang, J. Jia [et al.] // Cell Death Discov. - - Vol. 5. - Art. - Mode of access: https ://seafoodplus.info

Delivery of NGF to the brain: intranasal versus ocular administration in anti-NGF transgenic mice [Text] / S. Capsoni, S. Covaceuszach, G. Ugolini [et al.] // J. Alzheimers Dis. - - Vol. 16, № 2. - P.

Derivatives of erythropoietin that are tissue protective but not erythropoietic [Text] / M. Leist, P. Ghezzi, G. Grasso [et al.] // Science. - - Vol. , № -P.

Differential modulation of angiogenesis by erythropoiesis-stimulating agents in a mouse model of ischaemic retinopathy [Electronic resource] / C. M. Mc Vicar, L. M. Colhoun, J. L. Abrahams [et al.] // PLoS One. - - Vol. 5, № 7. - Art. e -Mode of access: seafoodplus.info?id=/seafoodplus.info

Dirnagl, U. Inflammation in stroke: the good, the bad, and the unknown [Text] / U. Dirnagl // Ernst Schering Res. Found. Workshop. - - Vol. - P.

Effects of the duration of dark adaptation on the retinal function of normal SD rats [Text] / L. Zahng, Y.-h. Gu, J. An [et al.] // Chin. J. Optometry Ophthalmol. Visual

Science. - - Vol. 15, № 6. - P.

Endemann, D. H. Endothelial dysfunction [Text] / D. H. Endemann, E. L. Schiffrin // J. Am. Soc. Nephrol. - - Vol. 15, № 8. - P.

Endogenous content of the nitric oxide in the cell layers of the eye retina [Text] / G. P. Kalamkarov, A. E. Bugrova, T. S. Konstantinova [et al.] // Ross. Fiziol. Zh. Im. I. M. Sechenova. - - Vol. , № 7. - P.

Endothelin [Text] / A. P. Davenport, K. A. Hyndman, N. Dhaun [et al.] // Pharmacol. Rev. - - Vol. 68, № 2. - P.

Endothelin-2 injures the blood-retinal barrier and macroglial muller cells: interactions with angiotensin II, aldosterone, and NADPH oxidase [Text] / S. F. Alrashdi, D. Deliyanti, D. M. Talia [et al.] // Am. J. Pathol. - - Vol. , № 3. -P.

Endothelinmediated protection of mutant photoreceptors in inherited photoreceptor degeneration [Electronic resource] / A. N. Bramall, M. J. Szego, L. R. Pacione [et al.] // PLoS One. - - Vol. 8, № 2. - Art. e - Mode of access: seafoodplus.info?id=/seafoodplus.info

Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade [Text] / M. C. Verhaar, F. E. Strachan, D. E. Newby [et al.] // Circulation. - - Vol. 97, № 8. - P.

Erden, S. Hypertensive retinopathy: incidence, risk factors, and comorbidities [Text] / S. Erden, E. Bicakci // Clin. Exp. Hypertens. - - Vol. 34, № 6. - P.

Erythropoietin (EPO): EPO-receptor signaling improves early endochondral ossification and mechanical strength in fracture healing [Text] / J. H. Holstein, M. D. Menger, C. Scheuer [et al.] // Life Sci. - - Vol. 80, № - P.

Erythropoietin amplifies stroke-induced oligodendrogenesis in the rat [Electronic resource] / L. Zhang, M. Chopp, R. L. Zhang [et al.] // PLoS ONE. - - Vol. 5, № 6. - Art. ID e - Mode of access:

seafoodplus.info?id=/seafoodplus.info&type=pr intable.

Erythropoietin and a nonerythropoietic peptide analog promote aortic endothelial cell repair under hypoxic conditions: role of nitric oxide [Text] / L. Heikal, P. Ghezzi, M. Mengozzi [et al.] // Hypoxia (Auckl.). - - Vol. 4. - P.

Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy [Text] / D. Watanabe, K. Suzuma, S. Matsui [et al.] // N. Engl. J. Med. - Vol. , № 8. - P.

Erythropoietin as neuroprotective and neuroregenerative treatment strategy: comprehensive overview of 12 years of preclinical and clinical research [Text] / D. Sargin, H. Friedrichs, A. El-Kordi [et al.] // Best Pract. Res. Clin. Anaesthesiol. - - Vol. 24, № 4. - P.

Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury [Text] / M. L. Brines, P. Ghezzi, S. Keenan [et al.] // Proc. Natl. Acad. Sci. USA. - - Vol. 97, № - P.

Erythropoietin improves long-term neurological outcome in acute ischemic stroke patients: a randomized, prospective, placebo-controlled clinical trial [Electronic resource] / T. H. Tsai, C. H. Lu, C. G. Wallace [et al.] // Crit. Care. - - Vol. -Art. - Mode of access: seafoodplus.info

Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor [Text] / M. Brines, G. Grasso, F. Fiordaliso [et al.] // Proc. Natl. Acad. Sci. U S A. - - Vol. , № - P.

Erythropoietin prevents long-term sensorimotor deficits and brain injury following neonatal hypoxia-ischemia in rats [Text] / E. Spandou, Z. Papadopoulou, V. Soubasi [et al.] // Brain Res. - - Vol. , № - P.

Erythropoietin regulates endothelial progenitor cells [Text] / F. H. Bahlmann, K. De Groot, J. M. Spandau [et al.] // Blood. - - Vol. , № 3. - P.

Erythropoietin selectively attenuates cytokine production and inflammation in

cerebral ischemia by targeting neuronal apoptosis [Text] / P. Villa, P. Bigini, T. Mennini [et al.] // J. Exp. Med. - - Vol. , № 6. - P.

Erythropoietin upregulates brain hemoglobin expression and supports neuronal mitochondrial activity [Text] / N. K. Singhal, K. Alkhayer, J. Shelestak [et al.] // Mol. Neurobiol. - - Vol. 55, № - P.

Erythropoietin-derived peptide protects against acute lung injury after rat traumatic brain injury [Text] / Y. Liu, J. Lu, X. Wang [et al.] // Cell. Physiol. Biochem. - - Vol. 41, № 5. - P.

Evaluation of hypertensive retinopathy through the oscillatory potentials of the electroretinogram [Text] / A. D. Negretto, A. A. Rosa, A. A. Nakashima [et al.] // Arq. Bras. Oftalmol. - - Vol. 71, № 1. - P.

Evaluation of target organ damage in arterial hypertension: which role for qualitative funduscopic examination? [Text] / C. Cuspidi, G. Macca, M. Salerno [et al.] // Ital. Heart J. - - Vol. 2, № 9. - P.

Expression of nitric oxide synthase in the retina of monocular deprivation amblyopia rats [Text] / Q. M. Wang, X. Y. Zhao, Z. Wang [et al.] // Eur. Rev. Med. Pharmacol. Sci. - - Vol. 22, № 7. - P.

Eye drop instillation of the Rac1 Modulator CNF1 attenuates retinal gliosis and ameliorates visual performance in a rat model of hypertensive retinopathy [Text] / A. Matteucci, L. Ricceri, A. Fabbri [et al.] // Neuroscience. - - Vol. - P.

Factors associated with changes in retinal microcirculation after antihypertensive treatment [Text] / P. R. Antonio, P. S. Marta, D. D. Luis [et al.] // J. Hum. Hypertens. - - Vol. 28, № 5. - P.

5, Methylenetetrahydrofolate reductase polymorphism and early organ damage in primary hypertension [Text] / M. Ravera, F. Viazzi, V. Berruti [et al.] // Am. J. Hypertens. - - Vol. 14, № 4, pt. 1. - P.

Fraser-Bell, S. Hypertensive eye disease: a review [Text] / S. Fraser-Bell, R. Symes, A. Vaze // Clin. Experiment. Ophthalmol. - - Vol. 45, № 1. - P.

Gallar, J. Activation of scleral cold thermoreceptors by temperature and blood flow changes [Text] / J. Gallar, M. C. Acosta, C. Belmonte // Invest. Ophthalmol. Vis. Sci. - - Vol. 44, № 2. - P.

Garcia-Rodriguez, J. C. The nasal route as a potential pathway for delivery of erythropoietin in the treatment of acute ischemic stroke in humans [Text] / J. C. Garcia-Rodriguez, I. Sosa-Teste // ScientificWorldJournal. - - Vol. 9. - P.

Genetically-modified human mesenchymal stem cells to express erythropoietin enhances differentiation into retinal photoreceptors: an in-vitro study [Text] / S. L. S Ding, A. E. Koh, S. Kumar [et al.] // J. Photochem. Photobiol. B. - - Vol. -P.

Goldstein, I. M. Nitric oxide: a review of its role in retinal function and disease [Text] / I. M. Goldstein, P. Ostwald, S. Roth // Vision Res. - - Vol. 36, № - P.

Gollasch, M. Perivascular adipose tissue and the dynamic regulation of Kv7 and Kir channels: implications for resistant hypertension [Electronic resource] / M. Gollasch, D. G. Welsh, R. Schubert // Microcirculation. - - Vol. 25, № 1. - Art. e - Mode of access: seafoodplus.info

Guthrie, M. J. Dual electroretinogram/nitric oxide carbon fiber microelectrode for direct measurement of nitric oxide in the in vivo retina [Text] / M. J. Guthrie, J. J. Kang-Mieler // IEEE Trans. Biomed. Eng. - - Vol. 61, № 3. - P.

Harjasouliha, A. Review of hypertensive retinopathy [Text] / A. Harjasouliha, V. Raiji, J. M. Garcia Gonzalez // Dis. Mon. - - Vol. 63, № 3. - P.

Hayreh, S. S. Ischemic optic neuropathies - where are we now? [Text] / S. S. Hayreh // Graefes Arch. Clin. Exp. Ophthalmol. - - Vol. , № 8. - P.

Hayreh, S. S. Prevalent misconceptions about acute retinal vascular occlusive disorders [Text] / S. S. Hayreh // Prog. Retin. Eye Res. - - Vol. 24, № 4. - P.

Helix B surface peptide administered after insult of ischemia reperfusion improved renal function, structure and apoptosis through beta common receptor/erythropoietin receptor and PI3K/Akt pathway in a murine model [Text] / C. Yang, T. Zhao, M. Lin [et al.] // Exp. Biol. Med. (Maywood). - - Vol. , № 1. - P.

HIFinduced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration [Text] / C. Grimm, A. Wenzel, M. Groszer [et al.] // Nat. Med. - - Vol. 8, № 7. - P.

Hypertension and the eye: changing perspectives [Text] / S. Chatterjee, S. Chattopadhyay, M. Hope-Ross [et al.] // J. Hum. Hypertens. - - Vol. 16, № -P.

Hypertension-related eye abnormalities and the risk of stroke [Text] / A. D. Henderson, B. B. Bruce, N. J. Newman [et al.] // Rev. Neurol. Dis. - - Vol. 8, № - P.

Hypertensive retinopathy an overview [Text] / A. R. Khurana, B. Khurana, S. Chauhan [et al.] // Haryana J. Ophthalmol. - - Vol. 7. - P.

Hypertensive retinopathy and cerebral small vessel disease in Amerindians living in rural Ecuador: The Atahualpa Project [Text] / O. H. Del Brutto, R. M. Mera,

E. M. Viteri [et al.] // Int. J. Cardiol. - - Vol. - P.

Hypertensive retinopathy and incident coronary heart disease in high risk men [Text] / B. B. Duncan, T. Y. Wong, H. A. Tyroler [et al.] // Br. J. Ophthalmol. - -Vol. 86, № 9. - P.

Hypertensive retinopathy and its association with cardiovascular, renal and cerebrovascular morbidity in Congolese patients [Text] / N. N. Kabedi, J. C. Mwanza,

F. B. Lepira [et al.] // Cardiovasc. J. Afr. - - Vol. 25, № 5. - P.

Hypertensive retinopathy and risk of stroke [Text] / Y. T. Ong, T. Y. Wong, R. Klein [et al.] // Hypertension. - - Vol. 62, № 4. - P.

Hypertensive retinopathy in a transgenic angiotensin-based model [Text] / N. Reichhart, N. Haase, S. Crespo-Garcia [et al.] // Clin. Sci. (Lond.). - - Vol. , № - P.

Induction of nitric oxide by erythropoietin is mediated by the {beta} common receptor and requires interaction with VEGF receptor 2 [Text] / L. Sautina, Y. Sautin, E. Beem [et al.] // Blood. - - Vol. , № 4. - P.

Intervention with an erythropoietin-derived peptide protects against neuroglial and vascular degeneration during diabetic retinopathy [Text] / C.M. McVicar, R. Hamilton, L.M. Colhoun [et al.] // Diabetes. - - Vol. 60, № - P.

Intranasal administration of erythropoietin rescues the photoreceptors in degenerative retina: a noninvasive method to deliver drugs to the eye [Text] / Y. Tao, C. Li, A. Yao [et al.] // Drug Deliv. - - Vol. 26, № 1. - P.

Intranasal erythropoietin ameliorates neurological function impairments and neural pathology in mice with chronic alcoholism by regulating autophagy-related Nrf2 degradation [Text] / X. Nie, W. Wang, Q. Wang [et al.] // Mol. Med Rep. - - Vol. 19, № 2. - P.

Intranasal erythropoietin protects CA1 hippocampal cells, modulated by specific time pattern molecular changes after ischemic damage in rats [Text] / R. J. Macias-Velez, L. Fukushima-Diaz de Leon, C. Beas-Zarate [et al.] // J. Mol. Neurosci. - Vol. 68, № 4. - P.

Intranasal erythropoietin therapy in nervous system disorders [Text] / S. Genc, Z. Zadeoglulari, M. G. Oner [et al.] // Expert Opin. Drug Deliv. - - Vol. 8, № 1. -P.

Intranasal recombinant human erythropoietin protects rats against focal cerebral ischemia [Text] / Y. P. Yu, Q. Q. Xu, Q. Zhang [et al.] // Neurosci. Lett. - Vol. , № 1. - P.

Is epsilon4 allele of apolipoprotein E associated with more severe end-organ damage in essential hypertension? [Text] / H. Yilmaz, T. Isbir, B. Agachan [et al.] // Cell Biochem. Funct. - - Vol. 19, № 3. - P.

Is leptin associated with hypertensive retinopathy? [Text] / G. Uckaya, M. Ozata, A. Sonmez [et al.] // J. Clin. Endocrinol. Metab. - - Vol. 85, № 2. - P.

Is there a relationship between blood pressure and intraocular pressure? An experimental study in hypertensive rats [Text] / A. Vaajanen, E. Mervaala, O. Oksala [et al.] // Curr. Eye Res. - - Vol. 33, № 4. - P.

Ischemic retinopathies: oxidative stress and inflammation [Electronic resource] / J. C. Rivera, R. Dabouz, B. Noueihed [et al.] // Oxid. Med. Cell. Longev. - -Vol. - Art. - Mode of access: seafoodplus.info

Jibran, M. S. Hypertensive retinopathy: a prognostic factor for morbidity and mortality after acute ST elevation myocardial infarction [Text] / M. S. Jibran, S. A. Habib, S. B. Khan // J. Coll. Physicians Surg. Pak. - - Vol. 29, № 3. - P.

Konstantinidis, L. Hypertension and the eye [Text] / L. Konstantinidis, Y. Guex-Crosier // Curr. Opin. Ophthalmol. - - Vol. 27, № 6. - P.

Kur, J. Cellular and physiological mechanisms underlying blood flow regulation in the retina and choroid in health and disease [Text] / J. Kur, E. A. Newman, T. Chan-Ling // Prog. Retin. Eye Res. - - Vol. 31, № 5. - P.

Lauver, D. A. Sulodexide: a renewed interest in this glycosaminoglycan [Text] / D. A. Lauver, B. R. Lucchesi // Cardiovasc. Drug Rev. - - Vol. 24, № - P.

Lehmann, M. V. Remodeling of retinal small arteries in hypertension [Text] / M. V. Lehmann, R. E. Schmieder // Am. J. Hypertens. - - Vol. 24, № - P.

Localized retinal nerve fiber layer defects and arterial hypertension [Text] / L. Xu, J. Q. Zhou, S. Wang [et al.] // Am. J. Hypertens. - - Vol. 26, № 4. - P.

Low-dose erythropoietin inhibits oxidative stress and early vascular changes in the experimental diabetic retina [Text] / Q. Wang, F. Pfister, A. Dorn-Beineke [et al.] // Diabetologia. - - Vol. 53, № 6. - P.

Maiese, K. Regeneration in the nervous system with erythropoietin [Text] / K. Maiese // Front. Biosci. (Landmark Ed.). - - Vol. - P.

McNally, M. A. Pharmacologic prevention and treatment of neonatal brain injury [Text] / M. A. McNally, J. S. Soul // Clin. Perinatol. - - Vol. 46, № 2. - P.

Mild retinopathy is a risk factor for cardiovascular mortality in Japanese with and without hypertension: the Ibaraki prefectural health study [Text] / T. Sairenchi, H. Iso, K. Yamagishi [et al.] // Circulation. - - Vol. , № - P.

Miller, N. R. Current concepts in the diagnosis, pathogenesis and management of nonarteritic anterior ischaemic optic neuropathy [Text] / N. R. Miller, A. C. Arnold // Eye (Lond). - - Vol. 29, № 1. - P.

Modi, P. Hypertensive retinopathy [Electronic resource] / P. Modi, T. Arsiwalla. - Treasure Island, FL : StatPearls Publ., - Mode of access: seafoodplus.info

Molecular clustering identifies complement and endothelin induction as early events in a mouse model of glaucoma [Text] / G. R. Howell, D. G Macalinao, G. L. Sousa [et al.] // J. Clin. Invest. - - Vol. , № 4. - P.

Morphometric analysis of small arteries in the human retina using adaptive optics imaging: relationship with blood pressure and focal vascular changes [Text] / E. Koch, D. Rosenbaum, A. Brolly [et al.] // J. Hypertens. - - Vol. 32, № 4. - P.

NeuroEPO preserves neurons from glutamate-induced excitotoxicity [Text] / F. Garzón, D. Coimbra, A. Parcerisas [et al.] // J. Alzheimers Dis. - - Vol. 65, № 4. - P.

Neuroprotection and angiogenesis: dual role of erythropoietin in brain ischemia [Text] / H. H. Marti, M. Bernaudin, E. Petit [et al.] // News Physiol. Sci. - - Vol. - P.

Neuroprotection of photoreceptors by direct delivery of erythropoietin to the retina of the retinal degeneration slow mouse [Text] / T. S. Rex, Y. Wong, K. Kodali [et

al.] // Exp. Eye Res. - - Vol. 89, № 5. - P.

Neuroprotection with an erythropoietin mimetic peptide (pHBSP) in a model of mild traumatic brain injury complicated by hemorrhagic shock [Text] / C. S. Robertson, L. Cherian, M. Shah [et al.] // J. Neurotrauma. - - Vol. 29, № 6. - P.

Neuroprotective effect of treatment with calcium antagonists on hypertensive retina [Text] / M. Sabbatini, D. Tomassoni, M. A. Di Tullio [et al.] // Clin. Exp. Hypertens. - - Vol. 24, № - P.

Neuroprotective effects of EpoL against oxidative stress induced by soluble oligomers of Aß peptide [Electronic resource] / C. Castillo, C. Fe rnandez-Mendivil, I. Buendia [et al.] // Redox Biol. - - Vol. - Art. - Mode of access: seafoodplus.info?via%3Dihub.

Neuroprotective potential of erythropoietin and darbepoetin alfa in an experimental model of sciatic nerve injury. Laboratory investigation [Text] / G. Grasso, F. Meli, V. Fodale [et al.] // J. Neurosurg. Spine. - - Vol. 7, № 6. - P.

Nonarteritic anterior ischemic optic neuropathy: cause, effect, and management [Text] / S. Berry, W. V Lin, A. Sadaka [et al.] // Eye Brain. - - Vol. 9. - P.

Nonerythropoietic erythropoietin-derived peptide suppresses adipogenesis, inflammation, obesity and insulin resistance [Electronic resource] / Y. Liu, B. Luo, R. Shi [et al.] // Sci. Rep. - - Vol. 5. - P. - Mode of access: seafoodplus.info

Nonerythropoietic tissue protective compounds are highly effective facilitators of wound healing [Text] / Z. Erbayraktar, S. Erbayraktar, O. Yilmaz [et al.] // Mol. Med. - - Vol. 15, № - P.

Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin [Text] / M. Brines, N. S. Patel, P. Villa [et al.] // Proc. Natl. Acad. Sci. USA. - - Vol. , № - P.

Oculars disturbances as first sign of decompensated arterial hypertension [Text] / A. Stepanov, J. Studnicka, L. Hejsek [et al.] // Cesk. Slov. Oftalmol. - -Vol. 70, № 5. - P.

Oscillatory potentials in subjects with treated hypertension [Text] / G. Ravalico, G. Rinaldi, N. Solimano [et al.] // Ophthalmologica. - - Vol. , № 4.

- P.

Ostrowski, D. Alternative erythropoietin receptors in the nervous system [Electronic resource] / D. Ostrowski, R. J. Heinrich // J. Clin. Med. - - Vol. 7, № 2. - Pii: E - Mode of access: seafoodplus.info

Pathological studies on the intracerebral and retinal arteries in cerebro-vascular and noncerebrovascular diseases [Text] / I. Goto, S. Katsuki, H. Ikui [et al.] // Stroke. - Vol. 6, № 3. - P.

Pharmacological preconditioning by recombinant erythropoietin - a new way of treatment of retinal ischemia/reperfusion [Text] / A. S. Shabelnikova, A. A. Peresypkina, M. V. Pokrovskii [et al.] // International journal of pharmacy & technology. - - Vol. 8, № 4. - P.

Pharmacological preconditioning by recombinant erythropoietin as the possibility of increasing the stability of tissue of the retina to reperfusion ischemia in experiment [Text] / A. S. Shabelnikova, A. A. Peresypkina, V. O. Gubareva [et al.] // Research Result: Pharmacology and Clinical Pharmacology. - - Vol. 2, № 1 (2).

- P.

Phipps, J. A. Retinal dysfunction in diabetic ren-2 rats is ameliorated by treatment with valsartan but not atenolol [Text] / J. A. Phipps, J. L Wilkinson-Berka, E. L. Fletcher // Invest. Ophthalmol. Vis. Sci. - - Vol. - P.

Porta, M. Hypertensive retinopathy: there's more than meets the eye [Text] / M. Porta, A. Grosso, F. Veglio // J. Hypertens. - - Vol. 23, № 4. - P.

Poulter, N. R. Independent effects of smoking on risk of hypertension: small, if present [Text] / N. R. Poulter // J. Hypertens. - - Vol. 20, № 2. - P.

Preeclampsia as predisposing factor for hypertensive retinopathy: Participation by the RAAS and angiogenic factors [Electronic resource] / C. Ramírez-Montero, V. Lima-Gómez, L. Anguiano-Robledo [et al.] // Eye Res. - - Vol. - Art. - Mode of access: seafoodplus.info%3Dihub.

Priming of late endothelial progenitor cells with erythropoietin before transplantation requires the CD receptor subunit and enhances their angiogenic potential [Text] / Y. Bennis, G. Sarlon-Bartoli, B. Guillet [et al.] // J. Thromb. Haemost. - - Vol. 10, № 9. - P.

Prospective cohort study of retinal vessel diameters and risk of hypertension [Electronic resource] / T. Y. Wong, A. Shankar, R. Klein [et al.] // BMJ. - - Vol. , № - Art. - Mode of access: seafoodplus.info

Quantitative mapping of scleral fiber orientation in normal rat eyes [Text] / M. J. A. Girard, A. Dahlmann-Noor, S. Rayapureddi [et al.] // Invest. Ophthalmol. Vis. Sci. - - Vol. 52, № - P.

Rabb, M. F. Retinal arterial macroaneurysms [Text] / M. F. Rabb, D. A. Gagliano, M. P. Teske // Surv. Ophthalmol. - - Vol. 33, № 2. - P.

Reduced functional deficits, neuroinflammation, and secondary tissue damage after treatment of stroke by nonerythropoietic erythropoietin derivatives [Text] / P. Villa, J. van Beek, A. K. Larsen [et al.] // J. Cereb. Blood Flow Metab. - - Vol. 27, № 3. - P.

Reichetzeder, C. Endothelin receptor antagonists in clinical research-lessons learned from preclinical and clinical kidney studies [Text] / C. Reichetzeder, O. Tsuprykov, B. Hocher // Life Sci. - - Vol. , № 2. - P.

Relation between grade II hypertensive retinopathy and coronary artery disease in treated essential hypertensives [Text] / G. H. Kim, H. J. Youn, S. Kang [et al.] // Clin. Exp. Hypertens. - - Vol. 32, № 7. - P.

Resistance to retinopathy development in obese, diabetic and hypertensive ZSF1 rats: an exciting model to identify protective genes [Electronic resource] / V. Caolo, Q. Roblain, J. Lecomte [et al.] // Sci. Rep. - - Vol. 8, № 1. - Art. -Mode of access: seafoodplus.info

Retinal microvascular abnormalities and renal dysfunction: the atherosclerosis risk in communities study [Text] / T. Y. Wong, J. Coresh, R. Klein [et al.] // J. Am. Soc. Nephrol. - - Vol. 15, № 9. - P.

Retinal microvascular abnormalities predict progression of brain microvascular disease: an atherosclerosis risk in communities magnetic resonance imaging study [Text] / T. C. Hanff, A. R. Sharrett, T. H. Mosley [et al.] // Stroke. - - Vol. 45, № 4. - P.

Retinal microvasculature as a model to study the manifestations of hypertension [Text] / C. Y. Cheung, M. K. Ikram, C. Sabanayagam [et al.] // Hypertension. - - Vol. 60, № 5. - P.

Retinal vascular features associated with risk of branch retinal vein occlusion [Text] / R. Kawasaki, E. Nagano, M. Uno [et al.] // Curr. Eye Res. - - Vol. 38, № 9. - P.

Retinal vascular signs and cerebrovascular diseases [Text] / T. H. Rim, A. W. J. Teo, H. H. S. Yang [et al.] // J. Neuroophthalmol. - - Vol. 40, № 1. - P.

Retinopathy and risk of congestive heart failure [Text] / T. Y. Wong, W. Rosamond, P. P. Chang [et al.] // JAMA. - - Vol. , № 1. - P.

RhoA/mDia-1/profilin-1 signaling targets microvascular endothelial dysfunction in diabetic retinopathy [Text] / Q. Lu, L. Lu, W. Chen [et al.] // Graefes Arch. Clin. Exp. Ophthalmol. - - Vol. , № 5. - P.

Rosenthal, J. M. Management of retinal diseases in pregnant patients [Text] / J. M. Rosenthal, M. W. Johnson // J. Ophthalmic Vis. Res. - - Vol. 13, № 1. - P.

Sachidanandam, R. Comparison between fullfield electroretinography obtained from handheld and tabletop devices in normal subjects [Text] / R. Sachidanandam, V. Khetan, P. Sen // Can. J. Ophthalmol. - - Vol. 50, № 2. - P.

Senescence-associated secretory phenotype contributes to pathological angiogenesis in retinopathy [Text] / M. Oubaha, K. Miloudi, A. Dejda [et al.] // Sci. Transl. Med. - - Vol. 8, № - P. ra

Shabelnikova, A. S. Correction of ischemic damage to the retina on application of pharmacological preconditioning of recombinant erythropoietin [Text] / A. S.

Shabelnikova // Research Result: Pharmacology and Clinical Pharmacology. - -Vol. 2, № 2 (3). - P.

Stryjewski, T. P. Multimodal imaging of Elschnig spots: a case of simultaneous hypertensive retinopathy, choroidopathy, and neuropathy [Text] / T. P. Stryjewski, T. D. Papakostas, D. Eliott // Semin. Ophthalmol. - - Vol. 32, № 4. -P.

Suppression of retinal neovascularization by erythropoietin siRNA in a mouse model of proliferative retinopathy [Text] / J. Chen, K. M. Connor, C. M. Aderman [et al.] // Invest. Ophthalmol. Vis. Sci. - - Vol. 50, № 3. - P.

Swept source optical coherence tomography evaluation of chorioretinal changes in hypertensive choroidopathy related to hellp syndrome [Text] / D. Velazquez-Villoria, P. Marti Rodrigo, M. L. DeNicola [et al.] // Retin. Cases Brief Rep. - -Vol. 13, № 1. - P.

Systemic diseases associated with various types of retinal vein occlusion [Text] / S. S. Hayreh, B. Zimmerman, M. J. McCarthy [et al.] // Am. J. Ophthalmol. - -Vol. , № 1. - P.

The association between endothelial dysfunction and hypertensive retinopathy in essential hypertension [Text] / M. Karaca, E. Coban, S. Ozdem [et al.] // Med. Sci. Monit. - - Vol. - P.

The deletion polymorphism of the angiotensin I-converting enzyme gene is associated with target organ damage in essential hypertension [Text] / R. Pontremoli, A. Sofia, A. Tirotta [et al.] // J. Am. Soc. Nephrol. - - Vol. 7, № - P.

The prepro vasoactive intestinal contractor (VIC)/endothelin-2 gene (EDN2): structure, evolution, production, and embryonic expression [Text] / K. Saida, M. Hashimoto, Y. Mitsui [et al.] // Genomics. - - Vol. 64, № 1. - P.

The renin-angiotensin system influences ocular endothelial cell proliferation in diabetes: transgenic and interventional studies [Text] / C. J. Moravski, S. L. Skinner, A. J. Stubbs [et al.] // Am. J. Pathol. - - Vol. , № 1. - P.

The vasoreparative potential of endothelial colony-forming cells in the

ischemic retina is enhanced by cibinetide, a non-hematopoietic erythropoietin mimetic [Text] / O. E. O'Leary, P. Canning, E. Reid [et al.] // Exp. Eye Res. - - Vol.

- P.

Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats [Text] / L. Wang, Z. Zhang, Y. Wang [et al.] // Stroke. - - Vol. 35, № 7. - P.

Tso, M. O. Pathophysiology of hypertensive retinopathy [Text] / M. O. Tso, L. M. Jampol // Ophthalmology. - - Vol. 89, № - P.

Update on retinal vascular caliber [Text] / A. G. Dumitrescu, L. Voinea, I. A. Badarau [et al.] // Rom. J. Ophthalmol. - - Vol. 61, № 3. - P.

Vascular stem cells and ischaemic retinopathies [Text] / A. W. Stitt, C. L. O'Neill, M. T. O'Doherty [et al.] // Prog. Retin. Eye Res. - - Vol. 30, № 3. - P.

Vasyuta, V. A. Study effect of assosiated pathology on the development of optic nerve atrophy [Text] / V. A. Vasyuta // Lik. Sprava. - - № - P.

Wilhelm, H. Non-arteritic ischemic optic neuropathy (NAION) [Text] / H. Wilhelm, F. Beisse, K. Rüther // Klin. Monbl. Augenheilkd. - - Vol. , №

- P.

Wong, T. Hypertensive retinopathy signs as risk indicators of cardiovascular morbidity and mortality [Text] / T. Wong, R. Mcintosh // Br. Med. Bull. - - Vol. - P.

Wong, T. Y. Hypertensive retinopathy [Text] / T. Y. Wong, P. Mitchell // N. Engl. J. Med. - - Vol. , № - P.

Wong, T. Y. The eye in hypertension [Text] / T. Y. Wong, P. Mitchell // Lancet. - - Vol. , № - P.

X-linked retinoschisis: RS1 mutation severity and age affect the ERG phenotype in a cohort of 68 affected male subjects [Text] / K. Bowles, C. Cukras, A. Turriff [et al.] // Invest. Ophthalmol. Vis. Sci. - - Vol. 52, № - P.

ПРИЛОЖЕНИЕ

Охранные документы на объекты интеллектуальной собственности